Niccolo Bacchi
Company: Borea Therapeutics
Job title: Chief Executive Officer
Seminars:
Addressing AAV Limitations with Ligand- Capsid Bioconjugation 12:00 pm
• How the ligand-capsid bioconjugation works: chemistry and process • Examples of ligands improving AAV characteristics • Future applications of AAV bioconjugationRead more
day: Day 1- Translation 1